Harold C. Smith, Ph.D. is the founder and CEO of CannaMetrix, LLC. He is professor emeritus in biochemistry and biophysics at the University of Rochester, School of Medicine and Dentistry following 39 years of academic research with the University and thought leadership in the field of RNA processing, funded through the NIH and the Bill and Melinda Gates foundation. His technical expertise, broad biomedical background and critical thinking skills have guided the
Company’s focus on biological potency testing services for cannabis and other nutraceuticals. Through cell and molecular engineering, the CannaMetrix team has established receptor- based potency testing in live human cells that has a large dynamic range, is high throughput, evergreen and low cost. The aim of the team is to support the medical cannabis industry with novel biological potency testing that will ensure that cannabis products are developed and processed consistently and with full knowledge of how they affect the human endocannabinoid system. Consumer safety and informed choice is our priority.
Charles Owen Wolffsmith Ph.D. is the CSO and lead scientist at CannaMetrix, LLC. He is an alumnus of the Biochemistry and Molecular Biology Graduate program at the University of Rochester, and has extensive training in Genetics, Pharmacology and Physiology, Metabolomics, and Bioenergetics. Using this experience he has lead the scientific program and built the CannaMetrix team that developed and tested the receptor-based potency testing technology in live human cells, and refined that testing platform to a high-throughput – industry ready – tool for determining the biologic potency of cannabinoids in blends and isolates.
Dr. Juan Sanchez Tamburrino is an accomplished leader with a Ph.D. in Molecular Biology and Genetics from Cornell University and a diverse career spanning the biotechnology, food, and life sciences industries. With a strong track record in innovation, product development, and international operations, Dr. Tamburrino has driven strategic growth for companies across the globe, from multinational corporations to micro-cap firms; including Dupont (Corteva), British American Tobacco and 22nd Century Group.
His expertise lies in merging cutting-edge technologies with commercial insights, fostering academic-industry collaborations, and managing complex R&D pipelines. He has successfully negotiated partnerships, developed IP strategies, and led cross-functional teams, all while focusing on advancing biotechnology solutions in sectors such as agronomics, biotechnology, and consumer products. Throughout his career, Dr. Sanchez has published over 24 journal articles and holds more than 30 patents, demonstrating his deep expertise and innovative contributions to the field. He brings a global perspective to his work, fostering strong relationships and partnerships across multiple industries and regions.
CSO, OyaGen, Inc
Founder and CEO of Green Express MD Dispensary
Professor, UR Medical Center
Professor, UR Medical Center
Professor, UR Medical Center
Founder and CEO of Certainty Cannabis Analytical Lab
Far far away, behind the word mountains, far from the countries Vokalia and Consonantia, there live the blind texts. Separated they.